Grants and Contributions
About this information
In June 2016, as part of the Open Government Action Plan, the Treasury Board of Canada Secretariat (TBS) committed to increasing the transparency and usefulness of grants and contribution data and subsequently launched the Guidelines on the Reporting of Grants and Contributions Awards, effective April 1, 2018.
The rules and principles governing government grants and contributions are outlined in the Treasury Board Policy on Transfer Payments. Transfer payments are transfers of money, goods, services or assets made from an appropriation to individuals, organizations or other levels of government, without the federal government directly receiving goods or services in return, but which may require the recipient to provide a report or other information subsequent to receiving payment. These expenditures are reported in the Public Accounts of Canada. The major types of transfer payments are grants, contributions and \'other transfer payments\'.
Included in this category, but not to be reported under proactive disclosure of awards, are (1) transfers to other levels of government such as Equalization payments as well as Canada Health and Social Transfer payments. (2) Grants and contributions reallocated or otherwise redistributed by the recipient to third parties; and (3) information that would normally be withheld under the Access to Information Act and the Privacy Act.
$361,400.00
Dec 1, 2021
Individual or sole proprietorship
Op. Gr.:Emerging COVID-19 Res. Gaps & Priorities - HIV and SARS-CoV-2
163306
Accelerate the availability and use of high-quality and real-time evidence and/or solutions to support Canada’s ongoing response to the pandemic in order to better prevent, detect, treat and manage COVID-19; AND
b. Generate evidence related to one or more marginalized population(s), including for instance: Black and other communities marginalized by race; First Nations, Inuit, Métis and Urban Indigenous Peoples; communities historically excluded from research; those experiencing health inequity; persons with disabilities and individuals across diverse health status (e.g. high risk populations, individuals with comorbid conditions); those experiencing gendered impacts of the pandemic; and those in life stages that have been underrepresented in research (e.g. pregnant people, children, older adults).
$500,000.00
Dec 1, 2021
Individual or sole proprietorship
Op. Gr.:Emerging COVID-19 Res. Gaps & Priorities - HIV and SARS-CoV-2
163305
Accelerate the availability and use of high-quality and real-time evidence and/or solutions to support Canada’s ongoing response to the pandemic in order to better prevent, detect, treat and manage COVID-19; AND
b. Generate evidence related to one or more marginalized population(s), including for instance: Black and other communities marginalized by race; First Nations, Inuit, Métis and Urban Indigenous Peoples; communities historically excluded from research; those experiencing health inequity; persons with disabilities and individuals across diverse health status (e.g. high risk populations, individuals with comorbid conditions); those experiencing gendered impacts of the pandemic; and those in life stages that have been underrepresented in research (e.g. pregnant people, children, older adults).
$286,800.00
Dec 1, 2021
Individual or sole proprietorship
Op. Gr.:Emerging COVID-19 Res. Gaps & Priorities - HIV and SARS-CoV-2
163308
Accelerate the availability and use of high-quality and real-time evidence and/or solutions to support Canada’s ongoing response to the pandemic in order to better prevent, detect, treat and manage COVID-19; AND
b. Generate evidence related to one or more marginalized population(s), including for instance: Black and other communities marginalized by race; First Nations, Inuit, Métis and Urban Indigenous Peoples; communities historically excluded from research; those experiencing health inequity; persons with disabilities and individuals across diverse health status (e.g. high risk populations, individuals with comorbid conditions); those experiencing gendered impacts of the pandemic; and those in life stages that have been underrepresented in research (e.g. pregnant people, children, older adults).
$7,000,000.00
Feb 1, 2023
For-profit organization
LAU-7b as next-generation COVID-19 therapeutic - COVID-19 Response-Stage 3 (TI): antiviral & Inflammation Controlling Therapeutic Drug Clinical Evaluation
1002706
The project is focusing on Phase 3 pivotal study of LAU-7b in moderate-to-severe hospitalized COVID-19 patients, and has a component allowing the transition to a new Phase 2 clinical development in mild-to-moderate non-hospitalized COVID-19 patients.
LAU-7b is a next-generation COVID-19 antiviral that addresses the gap between early infection and critical COVID-19 disease, and aims for broad applicability at-home or in hospital. Because its host-directed mechanism, LAU-7b has the potential to work on all mutations of COVID-19, and other coronaviruses. Results from the Phase 2 pilot study showed 100% reduction in the risk of progression to mechanical ventilation and death in hospitalized moderate-to-severe patient.
$1,783,815.00
Jun 1, 2024
For-profit organization
H5N1 -mRNA vaccine for Highly Pathogenic Avian Influenza for Protection of Canadian Livestock
1028947
Providence Therapeutics will initiate work to design and develop an mRNA vaccine drug candidate for a relevant strain using their mRNA and INTENT lipid nanoparticle (LNP) platforms.
$16,615.00
May 12, 2020
Not-for-profit organization or charity
Contribution to Mazaya Organization
16087
Supporting Jabra Hospital Intensive Care Unit for Sudan's Response to COVID19 through the Provision of Medical Supplies
$220,674.00
Jun 26, 2020
Not-for-profit organization or charity
Contribution to CAUSE Canada
16023
Preventing and responding to COVID-19 through community mobilization in the Koinadugu and Falaba Districts of Sierra Leone
$100,000.00
Jun 11, 2020
Not-for-profit organization or charity
Contribution to World Vision Eswatini
16110
Reduce the spread and impact of COVID-19 on children in Eswatini through increased awareness and service provision.
$49,500.00
Jun 8, 2020
Not-for-profit organization or charity
Contribution to Radio Moçambique (Radio Mozambique)
16113
Strenghtening informal street-vendors and public transport passenger's capacity to respond to COVID-19 through provision of information.
$79,000.00
Jun 16, 2020
Not-for-profit organization or charity
Contribution to Católicas por el derecho a decidir, A.C.
16115
Promoting assistance for victims of gender-based violence in the context of the COVID-19 emergency in Mexico